When the City Attacks Itself

Urban Autoimmunity — Why Urban Solutions Become the Source of the Crisis

There is a paradox at the heart of modern medicine that also resides at the heart of every major city: the system that exists to protect eventually turns against the very body it once served. In immunology, this phenomenon is classified as autoimmune disease — a family of more than eighty chronic conditions affecting between five and eight percent of the global population, all sharing one defining characteristic: no single cause. Researcher Antonios Theofilopoulos and his colleagues identified what they termed “the multiple pathways to autoimmunity,” establishing that the disease does not emerge from one isolable defect but from the simultaneous accumulation of interlocking pathways — genetic, environmental, cellular, and hormonal. The deeper paradox is that major cities, in the long arc of their development, suffer from precisely the same phenomenon.

The City as Living Organism — Its Networks as Immune System

Before this relationship is read as poetic metaphor, consider it as a genuine diagnostic framework. The human body comprises specialized, interdependent networks — an immune system, a nervous system, a hormonal equilibrium — each designed to protect the whole. The city contains their precise counterparts: a road network, a sewage system, an electrical grid, a housing stock, a services infrastructure. In their healthy state, these networks “recognize” what is compatible with urban tissue and what is hostile to it, much as the immune system distinguishes between self and foreign cells. When that discrimination fails — in the body or in the city — the system does not stop functioning. It continues with blind momentum, and that is exactly where the damage originates.

Theofilopoulos observed that self-reactive immune cells — the T cells and B cells responsible for autoimmune disease — do not perish. They escape the natural filtration mechanisms of the thymus and bone marrow and enter the body carrying a corrupted memory that causes them to identify healthy tissue as a threat. Urban planning carries a direct equivalent: policies constructed to address a genuine crisis that grew, over time, into the crisis itself. An expressway cut through the center of a city to relieve traffic congestion redistributes pressure onto secondary streets too fragile to absorb it. A social housing project that resolves a residential deficit in one district multiplies demand on infrastructure never designed for that density. In both cases, a sound intervention deployed in the wrong context generates a new pathological pathway.

Genetic Overlap — When Urban Crises Share the Same Root

Among the most significant findings to emerge from genome-wide association studies is that distinct autoimmune diseases — type 1 diabetes, rheumatoid arthritis, celiac disease — actually share portions of their genetic architecture. The Wellcome Trust Case Control Consortium documented this overlap, identifying that variants in the gene known as PTPN2 (protein tyrosine phosphatase non-receptor type 2) increase susceptibility to three different diseases simultaneously. In other words, the same genetic soil produces fertile ground for multiple conditions to ignite.

In architecture and urban planning, this corresponds to what might be called the systematic layering of design defects. Cities that experienced unregulated growth during the 1960s and 1970s — without enforced master plans or adequate oversight — developed a fragile urban genome: substandard infrastructure, road networks without the hierarchical logic needed to prioritize movement, and land-use mixing that no regulatory mechanism controlled. This genome does not produce a single failure. It renders the city combustible at any point: a traffic breakdown, a flooding event, a services collapse, a sewage failure. More critically, repairing one node without understanding the structural interdependency does not resolve the problem — just as targeting a single gene variant in an autoimmune patient does nothing to silence the remaining pathways.

Innate Sensing — How Systems Issue Warnings Before Collapse

Within the immune system, an innate sensing apparatus functions as an early-warning mechanism. Research published in 2024 by Ming Dong and Katya Fitzgerald in Nature Immunology demonstrated that this apparatus detects self-DNA leaking from damaged cells and triggers wide-scale inflammatory signals in response. The problem is that this alarm — conceptually correct — lacks proportionality: a small quantity of damaged genetic material provokes a response that attacks broad expanses of healthy tissue.

Cities possess analogous innate sensing systems: traffic databases, flood-warning networks, sewage monitoring reports. The real crisis occurs when administrative bodies respond to these signals with disproportionate intervention. A failed traffic signal at a major intersection is addressed by rerouting, loading a residential street with volumes it was never designed to carry. A fault in the electrical grid is handled by a partial cutoff that disrupts a wider circuit. This is precisely what the research describes as hyperactivation of innate nucleic acid sensors — an accurate alarm, a destructive response.

What Dong and Fitzgerald further identified is equally instructive: deficiencies in the clearance enzymes that should remove damaged DNA before it triggers the alarm allow material to accumulate until the inflammatory response becomes permanent. In architecture, this corresponds to the absence of proactive regulatory mechanisms — periodic reviews of building codes, land-use plan updates that precede rather than follow reality — so that violations accumulate to a point where any subsequent remediation requires demolishing what was built on top of them.

Inherited Tolerance — What the City Cannot Overcome Alone

Among the most consequential concepts in autoimmune science are “central tolerance” and “peripheral tolerance”: two consecutive stages in which the immune system learns not to attack its own cells. Theofilopoulos and colleagues documented that this learning fails at two distinct levels. The first is the formative stage in the thymus, where only sixty percent of potentially dangerous T cells are eliminated even under optimal conditions. The second is the subsequent peripheral surveillance stage, which depends on inhibitory molecules including CTLA-4 and PD-1 — and when these molecules are suppressed or disabled, self-reactive cells escape unchecked.

Urban planning presents two directly parallel stages: the initial decision-making phase — licensing, zoning plans, building codes — and the subsequent enforcement phase. Cities that established weak initial tolerance — permitting construction beyond setback lines, or approving densities that exceed network capacity — later discover that peripheral oversight alone cannot correct what has taken structural root. The city’s inhibitory molecules are the regulations that are actually enforced; when these are suppressed, whether through political pressure or an enforcement gap, the dangerous urban cells are released: unauthorized structures, uncontrolled densification, encroachment on agricultural land — each attacking the urban fabric it was nominally meant to belong to.

Molecular Mimicry — When the Intervention Targets the Wrong Address

The concept of molecular mimicry describes one of the more counterintuitive paradoxes in autoimmune disease: an invading pathogen carries a surface structure that resembles a self-protein, so the immune system attacks it successfully — while simultaneously damaging healthy cells that carry the same configuration. Research by María Rojas and colleagues, published in the Journal of Autoimmunity in 2018, documented this in precise terms: Campylobacter jejuni stimulates antibodies that paralyze human motor nerve endings, and the Epstein-Barr virus generates T cells that attack myelin sheaths.

In urban design, molecular mimicry occurs when successful solutions are borrowed from one context and applied literally to environments that do not share the same underlying structure. A grid street plan that performed well in mid-density American cities is transposed onto a high-density Arab urban environment with a different movement culture and produces a layout that resembles a solution while deepening the problem. A raised-and-ramped accessible kerb standard borrowed from European accessibility codes is installed on a street with a high water table and becomes, during the first rainy season, a reverse drainage channel. The form is correct; the body rejected it.

Rojas notes that molecular mimicry alone is insufficient to trigger disease — it requires a pre-existing genetic susceptibility and an enabling context. This is precisely what planners indicate when they observe that the problem is never the individual project, but the city’s structural receptivity to converting any intervention into a crisis.

Metabolic Adaptation — Where Chronic Crisis Finds Its Own Fuel

In recent years, autoimmune research has opened an entirely new line of inquiry: cellular metabolism. A study by Rita Mubariki and Ziv Vadasz, published in Autoimmunity Reviews in 2022, established that attacking immune cells reprogram their entire metabolic apparatus — consuming glucose at significantly higher rates and expanding their energy production through oxidative phosphorylation pathways. The crisis, in other words, does not wait for external resources. It generates its own energy from within the system.

This explains why urban crises persist even after substantial budgets are directed at them: the dysfunctional systems have developed their own mechanisms for survival and expansion. An informal settlement that has reorganized over decades into a complete parallel economy — with distribution networks, labor markets, and social structures — can resist any planning intervention that ignores this internal metabolism. The therapeutic approaches in immunology — metformin, which suppresses energy-production pathways, and rapamycin, which disrupts cellular growth pathways — find their planning equivalents in policies that address the fuel supply of parasitic systems rather than merely redecorating them: restructuring the licensing apparatus at its foundation, and formalizing the informal economy rather than treating it as an external problem.

Diagnosis Before Prescription

What Theofilopoulos and colleagues established is that no single cure exists for autoimmune diseases, because the disease does not arise from a single pathway. This is precisely where conventional urban planning has consistently fallen short — in its search for one solution to one crisis. The cities that achieve long-term stability are those that engage with their urban fabric as a multi-pathway biological system, not as a machine that can be repaired by replacing one component. Just as emerging technologies — single-cell RNA sequencing and antigen-specific CAR-Treg therapy — promise to transform the treatment of autoimmune conditions, new planning instruments — digital modeling, real-time movement data, artificial intelligence analytics — offer a comparable capacity to read the city as a living organism that can be understood and treated, rather than as an engineering problem that can be resolved with the next project.

✦ ArchUp Editorial Insight

The article deploys immunological research as a diagnostic lens for urban dysfunction, and the framework holds — not because cities resemble organisms in a poetic sense, but because both systems share the same structural failure mode: a protection apparatus that continues operating after its targeting logic has been corrupted.

What the research by Theofilopoulos and colleagues actually reveals, when read through a planning register, is that the most destructive urban interventions are not the ones that fail visibly at the moment of implementation. They are the ones that succeed locally and immediately — the expressway that clears the bottleneck, the housing block that fills the deficit — while silently redistributing load onto systems too fragile to absorb it, on timelines too long to attribute the damage to the original decision.

This is the liability transfer pattern operating at its most structurally complete: the decision-maker exits at the ribbon-cutting, the consequence materializes in the secondary street, the flooded basement, the overloaded trunk main, a decade later, absorbed entirely by the party who had no seat at the table where the zoning variance was approved.

The metabolic adaptation section is the most forensically precise passage in the article — informal settlements that have developed self-sustaining parallel economies do not resist planning intervention out of inertia; they resist it because the intervention is designed to eliminate the system without replacing the function it performs, which is the urban equivalent of suppressing an immune response without addressing the antigen that triggered it.

What this archive identified in the context of residential deterioration — that tenure insecurity produces rational concealment of decay, converting a maintenance problem into a structural one — operates through the same mechanism: the dysfunction generates its own continuity conditions, and any intervention that does not account for that internal metabolism will be metabolized by the system it intended to correct.

References

Theofilopoulos, Antonios; Kono, Diana; Baccala, Roberto. “The Multiple Pathways to Autoimmunity.” Nature Immunology, 2017.

Keller, Christian; Adamopoulos, Ilias; Lünemann, Jan. “Autophagy Pathways in Autoimmune Diseases.” Journal of Autoimmunity, 2023.

Mubariki, Rita; Vadasz, Ziv. “The Role of B Cell Metabolism in Autoimmune Diseases.” Autoimmunity Reviews, 2022.

Dong, Ming; Fitzgerald, Katya. “DNA-Sensing Pathways in Health, Autoinflammatory and Autoimmune Diseases.” Nature Immunology, 2024.

Rojas, María; Restrepo-Jiménez, Paola; Monsalve, Diana; et al. “Molecular Mimicry and Autoimmunity.” Journal of Autoimmunity, 2018.

Zhu, Di; Song, Wei; Jiang, Zhi; Zhou, Hang; Wang, Xia. “Citrullination: A Modification Important in the Pathogenesis of Autoimmune Diseases.” Clinical Immunology, 2022.

Chi, Xiao; Huang, Ming; Tu, Hao; et al. “Innate and Adaptive Immune Abnormalities Underlying Autoimmune Diseases: The Genetic Connections.” Science China Life Sciences, 2023.